Skip to Content

WPI 2264 (Acitretin 17.5 mg)

This pill with imprint "WPI 2264" is Yellow, Capsule-shape and has been identified as Acitretin 17.5 mg. It is supplied by Actavis Pharma, Inc..

Acitretin is used in the treatment of psoriasis; pityriasis rubra pilaris; psoriatic arthritis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 17.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2264

Acitretin

Imprint:
WPI 2264
Strength:
17.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antipsoriatics
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2264

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide